OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 24 citing articles:

Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK–mTOR Interplay
Huan Chen, Da T. Tran, Hsiu-Chiung Yang, et al.
Cardiovascular Drugs and Therapy (2020) Vol. 34, Iss. 4, pp. 443-461
Closed Access | Times Cited: 77

Endothelial cells, neutrophils and platelets: getting to the bottom of an inflammatory triangle
Tima Dehghani, Alyssa Panitch
Open Biology (2020) Vol. 10, Iss. 10
Open Access | Times Cited: 46

Small molecules as modulators of regulated cell death against ischemia/reperfusion injury
Dan‐Qian Chen, Yan Guo, Xin Li, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 6, pp. 2067-2101
Closed Access | Times Cited: 23

Fibroblasts and platelets: a face-to-face dialogue at the heart of cardiac fibrosis
Cécile Dufeys, Julie Bodart, Luc Bertrand, et al.
AJP Heart and Circulatory Physiology (2024) Vol. 326, Iss. 3, pp. H655-H669
Closed Access | Times Cited: 4

The Therapeutic Potential of Anticoagulation in Organ Fibrosis
Hanna Oh, Hye Eun Park, Min Su Song, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 15

A Comprehensive Review of the Pleiotropic Effects of Ticagrelor
Jeffrey Triska, Neil Maitra, Matthew R. Deshotels, et al.
Cardiovascular Drugs and Therapy (2022) Vol. 38, Iss. 4, pp. 775-797
Open Access | Times Cited: 14

What do we know about platelets in myocardial ischemia-reperfusion injury and why is it important?
Lun Wang, Yifan Liu, Ran Tian, et al.
Thrombosis Research (2023) Vol. 229, pp. 114-126
Closed Access | Times Cited: 6

The pleiotropic effects of antithrombotic drugs in the metabolic–cardiovascular–neurodegenerative disease continuum: impact beyond reduced clotting
Rana Alaaeddine, Ibrahim AlZaim, Safaa H. Hammoud, et al.
Clinical Science (2021) Vol. 135, Iss. 8, pp. 1015-1051
Closed Access | Times Cited: 13

Progress in the development and application of transitional technology of surface-enhanced Raman spectroscopy
Hao Liu, Xiaoying Liu, Luoqi Mo, et al.
Colloids and Interface Science Communications (2021) Vol. 43, pp. 100443-100443
Closed Access | Times Cited: 13

Ticagrelor reverses the mitochondrial dysfunction through preventing accumulated autophagosomes-dependent apoptosis and ER stress in insulin-resistant H9c2 myocytes
Yusuf Olğar, Erkan Tuncay, Deniz Billur, et al.
Molecular and Cellular Biochemistry (2020) Vol. 469, Iss. 1-2, pp. 97-107
Closed Access | Times Cited: 12

Do We Really Need Aspirin Loading for STEMI?
Regina Ye, Hani Jneid, Mahboob Alam, et al.
Cardiovascular Drugs and Therapy (2022) Vol. 36, Iss. 6, pp. 1221-1238
Open Access | Times Cited: 8

Cardiac fibrosis: emerging agents in preclinical and clinical development
Roberto Spoladore, Giulio Falasconi, Giorgio Fiore, et al.
Expert Opinion on Investigational Drugs (2020) Vol. 30, Iss. 2, pp. 153-166
Closed Access | Times Cited: 11

Ticagrelor and Dapagliflozin Have Additive Effects in Ameliorating Diabetic Nephropathy in Mice with Type-2 Diabetes Mellitus
Yochai Birnbaum, Huan Chen, Dat Q. Tran, et al.
Cardiovascular Drugs and Therapy (2021) Vol. 36, Iss. 5, pp. 829-840
Closed Access | Times Cited: 10

Cardioprotective effects of Moku-boi-to and its impact on AngII-induced cardiomyocyte hypertrophy
Hideaki Tagashira, Fumiha Abe, Kaori Sato, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 3

Ticagrelor as compared to conventional antiplatelet agents in coronary artery disease: A comprehensive meta-analysis of 15 randomized trials
Monica Verdoia, Stefano Savonitto, Dariusz Dudek, et al.
Vascular Pharmacology (2020) Vol. 137, pp. 106828-106828
Closed Access | Times Cited: 6

Pharmacological Approaches to Limit Ischemic and Reperfusion Injuries of the Heart: Analysis of Experimental and Clinical Data on P2Y12 Receptor Antagonists
Л. Н. Маслов, С. В. Попов, А. V. Mukhomedzyanov, et al.
Korean Circulation Journal (2022) Vol. 52, Iss. 10, pp. 737-737
Open Access | Times Cited: 3

Evaluation of the Effects of Dual Antiplatelet Therapy on Guided Bone Regeneration in Peri-Implant Bone Defect
Mehmet Ali Kobat, Serkan Dündar, Alihan Bozoğlan, et al.
Journal of Craniofacial Surgery (2022) Vol. 34, Iss. 5, pp. 1590-1594
Closed Access | Times Cited: 3

Ticagrelor Loading on ST-Elevation Myocardial Infarction: Interaction With Prodromal Angina on Infarct Size and Clinical Events
João Faria, Pedro Oliveira, André Alexandre, et al.
Journal of Cardiovascular Pharmacology and Therapeutics (2023) Vol. 28
Open Access | Times Cited: 1

Ticagrelor — a legend of modern cardiology
S. R. Gilyarevskiy
Russian Journal of Cardiology (2024) Vol. 29, Iss. 9, pp. 6052-6052
Open Access

Changes in cardiac cells due to ticagrelor and enoxaparin in a rat ischemia/reperfusion model
Orhan Fındık, Özgür Barış, Yusufhan Yazır, et al.
Revista da Associação Médica Brasileira (2021) Vol. 67, Iss. 12, pp. 1764-1770
Open Access | Times Cited: 3

The effects of dual anti-platelet therapy on titanium implant osseointegration: an experimental study
Mehmet Ali Kobat, Serkan Dündar, Alihan Bozoğlan, et al.
Journal of Health Sciences and Medicine (2022) Vol. 5, Iss. 1, pp. 144-149
Open Access

Effect of ticagrelor and prasugrel on remote myocardial inflammation in patients with acute myocardial infarction with ST-elevation: a CMR T1 and T2 mapping study
Lara S. F. Konijnenberg, Daša Zugwitz, Henk Everaars, et al.
The International Journal of Cardiovascular Imaging (2022) Vol. 39, Iss. 4, pp. 767-779
Closed Access

Page 1

Scroll to top